Scholarlink

<p>Chronic kidney disease (CKD) results in severe morbidity and mortality in children; thus early diagnosis is essential to minimize long-term effects. This research aimed to unveil potential saliva biomarkers for improving early CKD diagnosis, as a non-invasive alternative to blood. An untargeted metabolomics method based on LC-QTOF-MS was applied to unstimulated and acid-stimulated saliva samples from children and adolescents suffering from CKD and healthy subjects. Partial Least Squares Method-Discriminant Analysis (PLS-DA) revealed different metabolic profiles in unstimulated and acid-stimulated saliva samples. The features significantly altered were identified based on their MS and MS/MS spectra and the analytical standards. Prolylproline, leucyl-leucine and pyroglutamyl-leucine were found to be increased in unstimulated saliva of CKD patients, while creatine, n-butyrylcarnitine and palmitic acid were altered in stimulated saliva. Hierarchical cluster analysis showed better grouping with biomarkers altered in stimulated saliva samples. According to Receiver Operating Characteristic (ROC) curves generated using PLS-DA discriminant method, these biomarkers (AUC = 0.999) also provided better prediction accuracy than those in unstimulated samples (AUC = 0.874), demonstrating the relevance of the collection method in the metabolic profile of saliva. Hence, as long as the collection method is considered, the salivary metabolome was proven to be a tool of choice for pediatric CKD diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Untargeted salivary metabolomics for pediatric chronic kidney disease diagnosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月4日

查看全文
  • Nora Unceta,
  • Alicia Sánchez-Ortega,
  • Alberto Gómez-Caballero,
  • Lucia Diez-Caballero,
  • Sandra Benito,
  • Zuriñe Gómez de Balugera,
  • Julita Szulimowska,
  • Anna Zalewska,
  • Mateusz Maciejczyk,
  • Katarzyna Taranta-Janusz

摘要

Chronic kidney disease (CKD) results in severe morbidity and mortality in children; thus early diagnosis is essential to minimize long-term effects. This research aimed to unveil potential saliva biomarkers for improving early CKD diagnosis, as a non-invasive alternative to blood. An untargeted metabolomics method based on LC-QTOF-MS was applied to unstimulated and acid-stimulated saliva samples from children and adolescents suffering from CKD and healthy subjects. Partial Least Squares Method-Discriminant Analysis (PLS-DA) revealed different metabolic profiles in unstimulated and acid-stimulated saliva samples. The features significantly altered were identified based on their MS and MS/MS spectra and the analytical standards. Prolylproline, leucyl-leucine and pyroglutamyl-leucine were found to be increased in unstimulated saliva of CKD patients, while creatine, n-butyrylcarnitine and palmitic acid were altered in stimulated saliva. Hierarchical cluster analysis showed better grouping with biomarkers altered in stimulated saliva samples. According to Receiver Operating Characteristic (ROC) curves generated using PLS-DA discriminant method, these biomarkers (AUC = 0.999) also provided better prediction accuracy than those in unstimulated samples (AUC = 0.874), demonstrating the relevance of the collection method in the metabolic profile of saliva. Hence, as long as the collection method is considered, the salivary metabolome was proven to be a tool of choice for pediatric CKD diagnosis.